Business model

Business Model Drug Development

Within the business area of drug delivery, Nanologica has several ways of working and collaborating;

Licensing agreements/ technology transfer – developing new products for partner products
Technology provider – Fee for service contracts and feasibility trials
Development of own assets – Internal development programs

If you would like to know more about Nanologica’s different Drug Development projects and collaboration opportunities, please contact Ulf Ericsson, VP Drug Development ulf.ericsson@nanologica.com.

Nanologica is a Swedish life science tools company that develops, manufactures, and sells advanced consumables to pharmaceutical manufacturers. Nanologica’s products are specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Due to effective purification and a long lifetime for the products, they can increase productivity and reduce costs for pharmaceutical manufacturers. Nanologica operates in a global niche market that is growing as a result of increased demand for drugs for the treatment of diabetes and obesity. The company’s mission is to increase access to cost-effective drugs through its purification products and thereby contribute to more patients around the world having access to life-saving treatments. The company is headquartered in Södertälje and Nanologica’s share (NICA) is listed for trading on Nasdaq Stockholm Main Market.

Fatal error: Uncaught wfWAFStorageFileException: Unable to save temporary file for atomic writing. in /home/nanologi/public_html/wp-content/plugins/wordfence/vendor/wordfence/wf-waf/src/lib/storage/file.php:34 Stack trace: #0 /home/nanologi/public_html/wp-content/plugins/wordfence/vendor/wordfence/wf-waf/src/lib/storage/file.php(658): wfWAFStorageFile::atomicFilePutContents() #1 [internal function]: wfWAFStorageFile->saveConfig() #2 {main} thrown in /home/nanologi/public_html/wp-content/plugins/wordfence/vendor/wordfence/wf-waf/src/lib/storage/file.php on line 34